Senior Vice President and Head of US Business Development & Alliances, Otsuka America Pharmaceuticals
Ron is responsible for identifying novel new therapeutic programs for Otsuka to benefit patients globally. Ron joined Otsuka in 2017 with 24 years of Business Development and Alliance Management experience leading business teams in negotiating over $1.5 billion in announced pharma / biotech deals.
Ron has significant experience in external partnering in the Life Sciences field from his previous activities in large Pharma as well as biotech companies. Ron is a PhD graduate of the University of Rochester, and holds an MBA from Columbia Business School. He serves as Vice Chairman of the Licensing and Ventures Group at the University of Virginia, has been a board member or board observer to 8 biotech companies since 2014, and was a member of the Scientific Advisory Board to NeoMED from 2013-17.